Please join Dr. Carter Thorne and Dr. Philip Baer for an in-depth discussion pertaining to CIBRN Question 3 & Question 4 surrounding the implications of the evolving Biosimilar landscape on clinical practice and patient health in Canada.
This webinar is intended for the CIBRN Rheumatology subgroup and is scheduled for Thursday, December 1st 6:30-7:30pm EST. See instructions below:
Step 1: To join the audio portion:
Dial toll-free: 1-866-830-9434
Enter Participant Code: 7994216
Step 2: To join the web portion:
Click on link: https://studio7communications.adobeconnect.com/cibrn_rheumatology/
Enter your name
Prior to the webinar, you are invited to visit the CIBRN community on Sosido to review the questions & responses and to reply with your personal clinical perspectives. The webinar will be recorded and archived for future viewing by the CIBRN community.
If you have any comments or questions, please contact me at your convenience.
If you have never attended an Adobe Connect meeting before:
Test your connection: https://studio7communications.adobeconnect.com/common/help/en/support/meeting_test.htm
Get a quick overview: http://www.adobe.com/products/adobeconnect.html